Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia-Reference-Cited by-同舟云学术

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia

Published:2011-09-26 Issue:10 Volume:15 Page:2117-2129
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:

Author:

See Fiona,Seki Tetsunori,Psaltis Peter J.,Sondermeijer Hugo P.,Gronthos Stan,Zannettino Andrew C.W.,Govaert Klaas M.,Schuster Michael D.,Kurlansky Paul A.,Kelly Darren J.,Krum Henry,Itescu Silviu

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1582-4934.2010.01241.x/fullpdf

Reference34 articles.

1. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction;Amado;Proc Natl Acad Sci USA.,2005

2. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium;Martens;Nat Clin Pract Cardiovasc Med,2006

3. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells;Nakanishi;Biochem Biophys Res Commun.,2008

4. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model;Silva;Circulation.,2005

5. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart;Terrovitis;Circulation.,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations;Journal of Translational Medicine;2024-05-15

2. Identification of a novel, MSC-induced macrophage subtype via single-cell sequencing: implications for intervertebral disc degeneration therapy;Frontiers in Cell and Developmental Biology;2024-01-11

3. Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome;JTCVS Open;2023-12

4. Mesenchymal STRO-1/STRO-3⁺ precursor cells for the treatment of chronic heart failure with reduced ejection fraction;Future Cardiology;2023-11-07

5. Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee;Cytotherapy;2023-10